adalimumab,ATV02
abbvie,Alvotech Holdings S.A.
['adalimumab', 'ease,(-please),(-disease),(-incrrease),(-decrease)']
join us at acr convergence, where we'll present data from our switching study for atv02, a proposed high-concentration (100 mg/ml), citrate-free, interchangeable adalimumab #biosimilar. read the press release #acr22 #rheumatologyadd 
Better Access. Better Lives.